X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
The Indian ‘beauties’ beckon - Views on News from Equitymaster
 
 
  • PRINT
  • E-MAIL
  • FEEDBACK
  • A  A  A
  • Sep 13, 2000

    The Indian ‘beauties’ beckon

    The Indian consumer never had it so good. Gone are the days when the cosmetics segment was largely identified with Lakme, Ponds and a host of locally made creams. International bigwigs like Revlon, Avon, Estee Lauder, Christian Dior and J. K. Hellen Curtis are all vying with each other to capture the Indian cosmetics freak. The question is what are all these fashion powerhouses doing in a country with a per capita income of about US$ 400.

    All these MNC’s are facing intensive competition in the developed world, where the market size has stagnated and hence the look out for additional markets with burgeoning middle class like China and India.

    Let us try and understand the dynamics of this ‘dynamic’ segment.

    The Indian Skin-care market valued between Rs 6-6.5 bn is growing at an impressive 22%. The segment can be broadly classified into 2 sub-segments:

    • The Fairness segment (50% of the total market)
    • The Non-fairness segment (50%)

    Out of these, the fairness market is growing faster at 30% per annum, whereas, the non-fairness segment is growing at a steady 15%.

    The Fairness segment
    Fairness creams command over 95% of this market. Fairness lotions have not been so popular and are losing market shares heavily. Hindustan Lever’s (HLL) Fair & Lovely dominates 90% of this segment and a hefty 45% of the total skin care market (in value terms).

    Southern India is skewed towards fairness cream consumption. Over 60% of its cosmetic spends are on fairness creams and lotions.

    The Non-fairness segment
    The segment is highly fragmented and different brands dominate each fragment. The segments include cleansers, cold creams, gels, nail polishes, eyeliners etc. Cleansers are the largest contributors in this category and accounts for about 10% of the total skin-care market. Cleansers can be classified into 4 segments:

    • Face wash (50% of all cleansers)
    • Cleansing milk (20%)
    • Deep cleansers (15%)
    • Astringent (15%)

    HLL owned Lakme and Ponds dominate this segment. Lakme and Ponds each account for over 10% of the total skin care market (Rs 60-65 m each). In all, HLL effectively controls 65% of the total skin care market (around Rs 4 bn), if we add its Fair & Lovely contributions also.

    Since new entrants cannot fight the heavy weights in the volume driven fairness segment, they have entered the non-fairness segment, positioning their products based on superior attributes to the upper end consumer in the urban market. Their distribution is at select up town stores and through personalised selling. Realising that the skin–care segment is brand sensitive, their aim is to earn a fan following in niche segments and then introduce a spate of products as brand extensions. They are looking at small volumes but big numbers.

    The successes of Indian ladies at International beauty pageants (Miss World and Miss Universe) will only add fuel to this already growing segment.

     

     

    Equitymaster requests your view! Post a comment on "The Indian ‘beauties’ beckon". Click here!

      
     

    More Views on News

    Marico: Earnings Hit by Lower Volumes and Firming Input Prices (Quarterly Results Update - Detailed)

    Aug 9, 2017

    While GST implementation brought down volumes and profitability in the short run, Marico remains optimistic in the long run.

    P&G: Strong Core Growth (Quarterly Results Update - Detailed)

    Dec 9, 2016

    Procter & Gamble Hygiene and Health Care has announced the first quarter results of the financial year ended June 2017 (1QFY17). The company's sales rose by 12.5%YoY while net profit rose by 50.1% YoY during the quarter.

    Nestle India: Sales Traction From New Products (Quarterly Results Update - Detailed)

    Nov 30, 2016

    Nestle India declared results for the quarter ended September 2016. Here is our analysis of the result.

    GSK Consumer: Price Hike Hurts Volumes (Quarterly Results Update - Detailed)

    Nov 30, 2016

    GSK Consumer Healthcare declared results for the quarter ended September 2016. The revenues dropped by 1.3% during the quarter as compared to a year ago; while the profits declined by 16.6% YoY during the quarter.

    Marico: Margin Expansion Drives Profit Growth (Quarterly Results Update - Detailed)

    Nov 28, 2016

    Marico has reported a flat topline while the bottomline has grown by 18% YoY during the quarter.

    More Views on News

    Most Popular

    A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

    Aug 10, 2017

    Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

    The Most Profitable Investment in the History of the World(Vivek Kaul's Diary)

    Aug 8, 2017

    'Yes, it looks like a bubble. And, yes, it's like buying a lottery ticket. But there's something happening that has never happened before. It's an evolutionary leap in money itself.'

    Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

    Aug 8, 2017

    Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

    Signs of Life in the India VIX(Daily Profit Hunter)

    Aug 12, 2017

    The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

    Bitcoin Continues Stellar Rise(Chart Of The Day)

    Aug 10, 2017

    Bitcoin hits an all-time high, is there more upside left?

    More
    Copyright © Equitymaster Agora Research Private Limited. All rights reserved.
    Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

    LEGAL DISCLAIMER: Equitymaster Agora Research Private Limited (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA or Canada, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.

    SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

    Equitymaster Agora Research Private Limited. 103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
    Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: info@equitymaster.com. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407
     

    Become A Smarter Investor In
    Just 5 Minutes

    Multibagger Stocks Guide 2017
    Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
    We will never sell or rent your email id.
    Please read our Terms

    S&P BSE FMCG


    Aug 18, 2017 (Close)

    S&P BSE FMCG 5-YR ANALYSIS

    COMPARE COMPANY

    MARKET STATS